285 related articles for article (PubMed ID: 23594312)
1. Ethics of ARV based prevention: treatment-as-prevention and PrEP.
Haire B; Kaldor JM
Dev World Bioeth; 2013 Aug; 13(2):63-9. PubMed ID: 23594312
[TBL] [Abstract][Full Text] [Related]
2. From modeling to morals: imagining the future of HIV PREP in Lesotho.
Kenworthy NJ; Bulled N
Dev World Bioeth; 2013 Aug; 13(2):70-8. PubMed ID: 23800326
[TBL] [Abstract][Full Text] [Related]
3. HIV treatment as prevention: population effect vs. individual protection?
Ippolito G; Rezza G
Ann Ig; 2013; 25(2):93-7. PubMed ID: 23471446
[TBL] [Abstract][Full Text] [Related]
4. Ethical use of antiretroviral resources for HIV prevention in resource poor settings.
Rennie S
Dev World Bioeth; 2013 Aug; 13(2):79-86. PubMed ID: 23724978
[TBL] [Abstract][Full Text] [Related]
5. Separate goals, converging priorities: on the ethics of treatment as prevention.
Ostmann F; Saenz C
Dev World Bioeth; 2013 Aug; 13(2):57-62. PubMed ID: 23800304
[TBL] [Abstract][Full Text] [Related]
6. HIV transmission law in the age of treatment-as-prevention.
Haire B; Kaldor J
J Med Ethics; 2015 Dec; 41(12):982-6. PubMed ID: 26420071
[TBL] [Abstract][Full Text] [Related]
7. Anti-retrovirals for treatment and prevention--time for new paradigms in our response to the HIV/AIDS epidemic?
Abdool Karim Q; Bayer R
Dev World Bioeth; 2013 Aug; 13(2):ii-iii. PubMed ID: 23865982
[No Abstract] [Full Text] [Related]
8. [Antiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?].
Supervie V
Med Sci (Paris); 2013 Apr; 29(4):373-82. PubMed ID: 23621932
[TBL] [Abstract][Full Text] [Related]
9. Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges.
McMahon JM; Myers JE; Kurth AE; Cohen SE; Mannheimer SB; Simmons J; Pouget ER; Trabold N; Haberer JE
AIDS Patient Care STDS; 2014 Sep; 28(9):462-74. PubMed ID: 25045996
[TBL] [Abstract][Full Text] [Related]
10. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
Verguet S; Stalcup M; Walsh JA
Sex Transm Infect; 2013 Dec; 89(8):628-34. PubMed ID: 23912819
[TBL] [Abstract][Full Text] [Related]
11. Preexposure prophylaxis for the prevention of HIV transmission to women.
Aaron E; Cohan D
AIDS; 2013 Jan; 27(1):F1-5. PubMed ID: 22914582
[TBL] [Abstract][Full Text] [Related]
12. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.
van der Straten A; Stadler J; Luecke E; Laborde N; Hartmann M; Montgomery ET;
J Int AIDS Soc; 2014; 17(3 Suppl 2):19146. PubMed ID: 25224610
[TBL] [Abstract][Full Text] [Related]
13. Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.
Kesho Bora Study Group
Contemp Clin Trials; 2011 Jan; 32(1):74-85. PubMed ID: 20854932
[TBL] [Abstract][Full Text] [Related]
14. The use of antiretroviral therapy for the prevention of new HIV infection in populations at high risk for HIV sero-conversion in Nigeria.
Idoko J; Folayan MO
Afr J Reprod Health; 2014 Sep; 18(3 Spec No):127-34. PubMed ID: 26050385
[TBL] [Abstract][Full Text] [Related]
15. Microbicides-emerging essential pillars of comprehensive HIV/AIDS prevention.
Gaym A
Ethiop Med J; 2006 Oct; 44(4):405-15. PubMed ID: 17370443
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral prophylaxis for sexual and injection drug use acquisition of HIV.
Campbell JD; Herbst JH; Koppenhaver RT; Smith DK
Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S63-9. PubMed ID: 23253764
[TBL] [Abstract][Full Text] [Related]
17. The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review.
Hankins CA; Dybul MR
Curr Opin HIV AIDS; 2013 Jan; 8(1):50-8. PubMed ID: 23201856
[TBL] [Abstract][Full Text] [Related]
18. Ethical considerations in determining standard of prevention packages for HIV prevention trials: examining PrEP.
Haire B; Folayan MO; Hankins C; Sugarman J; McCormack S; Ramjee G; Warren M
Dev World Bioeth; 2013 Aug; 13(2):87-94. PubMed ID: 23725227
[TBL] [Abstract][Full Text] [Related]
19. Exposure ethics: does HIV pre-exposure prophylaxis raise ethical problems for the health care provider and policy maker?
Venter F; Allais L; Richter M
Bioethics; 2014 Jul; 28(6):269-74. PubMed ID: 23796241
[TBL] [Abstract][Full Text] [Related]
20. Preexposure prophylaxis (PrEP) of HIV infection in France: a nationwide cross-sectional study (PREVIC study).
Rosenthal E; Piroth L; Cua E; Joulié A; Ravaux I; Chauveau M; Lacombe K; Cotte L; Bonnard P; Weiss L; Longuet M; Pradier C; Cacoub P;
AIDS Care; 2014 Feb; 26(2):176-85. PubMed ID: 23756091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
